Upgrade to SI Premium - Free Trial

Replimune (REPL)

8.74 -0.73 (7.71%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (6/8/26)

Latest Headlines

Form 4 Replimune Group, Inc. For: Jun 01 Filed by: Sarchi Christopher June 3, 2026 8:30 PM - SEC Filing Replimune (REPL) call put ratio 1 call to 1.2 put amid sharp rally June 1, 2026 5:42 AM - StreetInsider Replimune presents final data for RP2 cancer treatment at oncology meeting June 1, 2026 2:53 AM - StreetInsider JPMorgan Upgrades Replimune Group (REPL) to Neutral June 1, 2026 1:06 AM - StreetInsider Replimune Presents Final First-in-Human Data for RP2 in Advanced Solid Tumors During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting May 31, 2026 8:00 AM - Globe NewsWire Replimune Presents 3-Year Landmark Overall Survival Analysis from IGNYTE Clinical Trial During Oral Presentation at the 2026 American Society of Clinical Oncology Annual Meeting May 30, 2026 8:00 AM - StreetInsider JPMorgan Upgrades Replimune Group (REPL) to Neutral May 29, 2026 1:15 PM - StreetInsider Replimune (REPL) call put ratio 1.4 calls to 1 put as share price up 83% May 29, 2026 10:49 AM - StreetInsider Form 8-K Replimune Group, Inc. For: May 29 May 29, 2026 9:56 AM - SEC Filing Replimune plans RP1 cancer drug resubmission after FDA talks May 29, 2026 8:01 AM - StreetInsider Replimune Announces Planned RP1 BLA Resubmission Following Productive Discussion with FDA May 29, 2026 8:00 AM - Globe NewsWire Replimune To Resubmit Melanoma Treatment For Fda Approval - WSJ May 29, 2026 7:33 AM - StreetInsider Form SCHEDULE 13G Replimune Group, Inc. Filed by: Ridgeback Capital Investments L.P. May 21, 2026 5:24 PM - SEC Filing Form 4 Replimune Group, Inc. For: May 18 Filed by: Xynos Konstantinos May 20, 2026 4:18 PM - SEC Filing Form 4 Replimune Group, Inc. For: May 18 Filed by: Schwendenman Andrew May 20, 2026 4:18 PM - SEC Filing Form 4 Replimune Group, Inc. For: May 18 Filed by: Sarchi Christopher May 20, 2026 4:17 PM - SEC Filing Form 4 Replimune Group, Inc. For: May 18 Filed by: Astley-Sparke Philip May 20, 2026 4:16 PM - SEC Filing Form 4 Replimune Group, Inc. For: May 18 Filed by: Patel Sushil May 20, 2026 4:16 PM - SEC Filing Form 4 Replimune Group, Inc. For: May 18 Filed by: Hill Emily Luisa May 20, 2026 4:16 PM - SEC Filing Form SCHEDULE 13G/A Replimune Group, Inc. Filed by: RTW INVESTMENTS, LP May 15, 2026 8:30 AM - SEC Filing Form SCHEDULE 13G Replimune Group, Inc. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC May 12, 2026 6:32 PM - SEC Filing FDA Commissioner Marty Makary is resigning - Politico reporter on X May 12, 2026 12:49 PM - StreetInsider Replimune shares surge on report Trump to dismiss FDA chief Makary May 8, 2026 1:32 PM - StreetInsider Form SCHEDULE 13G/A Replimune Group, Inc. Filed by: PRICE T ROWE ASSOCIATES INC /MD/ May 7, 2026 11:05 AM - SEC Filing Replimune to Present at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting April 27, 2026 8:00 AM - Globe NewsWire Increasing unusual option volume: REPL ALLO CORN ALMU IDYA TPG CNK PLCE IVR VIST TVTX April 14, 2026 10:44 AM - StreetInsider Increasing unusual option volume: REPL ALLO CORN ALMU IDYA TPG CNK PLCE IVR VIST TVTX April 13, 2026 10:15 AM - StreetInsider Replimune sinks 57% on second FDA rejection of melanoma drug; stock downgraded April 13, 2026 6:44 AM - StreetInsider Wedbush Downgrades Replimune Group (REPL) to Neutral April 13, 2026 6:09 AM - StreetInsider Leerink Partners Downgrades Replimune Group (REPL) to Market Perform April 13, 2026 6:08 AM - StreetInsider H.C. Wainwright Downgrades Replimune Group (REPL) to Sell April 13, 2026 6:08 AM - StreetInsider Form 8-K Replimune Group, Inc. For: Apr 10 April 13, 2026 6:02 AM - SEC Filing BMO Capital Downgrades Replimune Group (REPL) to Underperform April 13, 2026 3:41 AM - StreetInsider Jefferies Downgrades Replimune Group (REPL) to Hold April 13, 2026 3:41 AM - StreetInsider JPMorgan Downgrades Replimune Group (REPL) to Underweight April 13, 2026 1:54 AM - StreetInsider Replimune receives FDA rejection for melanoma treatment RP1 April 10, 2026 5:04 PM - StreetInsider Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma April 10, 2026 5:02 PM - Globe NewsWire Cantor Fitzgerald Downgrades Replimune Group (REPL) to Neutral April 10, 2026 4:04 PM - StreetInsider Piper Sandler Downgrades Replimune Group (REPL) to Neutral April 10, 2026 3:38 PM - StreetInsider Jefferies on Iovanace Biotherapeutics (IOVA): 'we think the pot'l risk of competition was accounted for in Street models' April 10, 2026 1:20 PM - StreetInsider Replimune (REPL) gets CRL from FDA April 10, 2026 11:18 AM - StreetInsider Replimune (REPL) Halted on Volatility, Down 8% April 10, 2026 10:57 AM - StreetInsider Form 4 Replimune Group, Inc. For: Apr 01 Filed by: BAKER JULIAN April 7, 2026 9:15 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Sarchi Christopher April 7, 2026 9:12 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Astley-Sparke Philip April 7, 2026 9:11 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Oliger Christy J. April 7, 2026 9:11 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Xynos Konstantinos April 7, 2026 9:10 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Balachandran Madhavan April 7, 2026 9:10 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Schwendenman Andrew April 7, 2026 9:10 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Patel Sushil April 7, 2026 9:09 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Dhingra Kapil April 7, 2026 9:09 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Pucci Paolo April 7, 2026 9:09 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: SLATTERY JOSEPH P April 7, 2026 9:08 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Peeples-Dyer Veleka April 7, 2026 9:08 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Hill Emily Luisa April 7, 2026 9:08 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 01 Filed by: Weinand Dieter April 7, 2026 9:08 PM - SEC Filing Form 4 Replimune Group, Inc. For: Apr 02 Filed by: Sarchi Christopher April 6, 2026 4:31 PM - SEC Filing Increasing unusual option volume: VFS CORN CODI BIZD CWAN REPL April 5, 2026 10:29 AM - StreetInsider Form 144 Replimune Group, Inc. Filed by: Sarchi Christopher April 2, 2026 4:16 PM - SEC Filing Full Article List